Bypaneni, V. et al. 2026. Risk Assessment and Analytical Control of Nitrosamine and NDSRI Impurities in Pharmaceutical Dosage Forms. International Journal of Pharma and Bio Sciences. 17, 2 (Jun. 2026), 1–9.